Background Image
Table of Contents Table of Contents
Previous Page  8 / 60 Next Page
Information
Show Menu
Previous Page 8 / 60 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 2, March/April 2021

62

AFRICA

Cardiovascular Topics

The spectrum of rheumatic mitral valve regurgitation

presenting to Inkosi Albert Luthuli Central Hospital,

KwaZulu-Natal, over a 10-year period

Nomthandazo Lynn Zwane, Somalingum Ponnusamy, Datshana Prakesh Naidoo

Abstract

Background:

Recent evidence suggests that there is a change

in the profile of rheumatic mitral regurgitation (MR) in South

Africa to a pattern of chronic fibrotic valvular disease.

Objective:

This study describes the clinical profile of patients

with rheumatic MR in the province of KwaZulu-Natal

(KZN).

Methods:

A retrospective chart review was performed on

patients seven years and older with moderate to severe rheu-

matic MR referred to Inkosi Albert Luthuli Central Hospital

from 2006 to 2015.

Results:

There were 320 patients meeting the study criteria

(mean age 22.2 ± 15.8 years, male:female 1:2). Severe dys-

pnoea was present in 45.9% of patients, heart failure in 117

(36.6%) and atrial fibrillation in 13.8%. Three patients were

diagnosed with active carditis at initial presentation and a

further 31 had evidence of carditis during follow up. Of the

216 patients who underwent surgery, over one-third (37%)

had prolapse of the anterior mitral leaflet, which was due to

chordal elongation (

n

= 63, 29.2%) and/or ruptured chordae

(

n

= 41, 19%). There were 32 deaths (10%) and of these, 27

(8.4%) patients died prior to surgery.

Conclusion:

Rheumatic MR in KZN predominantly affects

the young, with concomitant carditis resulting in high morbid-

ity and mortality rates.

Keywords:

rheumatic MR, rheumatic carditis, echocardiography,

chordal elongation, mitral valve surgery

Submitted 26/2/20, accepted 14/7/20

Published online 16/3/21

Cardiovasc J Afr

2021;

32

: 62–69

www.cvja.co.za

DOI: 10.5830/CVJA-2020-029

The epidemiology of non-communicable diseases in low- and

middle-income countries highlights rheumatic heart disease

(RHD) as one of the leading causes of death, accounting for up

to 1.4 million deaths worldwide per year.

1,2

The gravity of this

problem is defined by the degree of complications associated

with the disease, such as atrial fibrillation, heart failure, stroke,

infective endocarditis and death.

3-7

Recent hospital-based studies

in South Africa (SA) reveal an incidence of congestive heart

failure secondary to RHD of 25 cases per 100 000 per year.

8,9

Despite the magnitude of the problem, there is a paucity of

data on the disease characteristics, including the demographic

pattern, clinical presentations, complications and management

in the majority of South African provinces, KwaZulu-Natal

(KZN) included.

9

In light of this problem, the World Health

Organisation (WHO) has called for a clear documentation of the

contemporary clinical characteristics of the disease together with

notification of new cases,

10

and has targeted a 25% reduction in

mortality rate from RHD and other non-communicable diseases

by the year 2025.

10

During the 2016 National Rheumatic Fever

week, it was pointed out that SA has the conditions required for

successful eradication of RHD, provided detailed characteristics

of the disease are well documented and ensuing guidelines

implemented.

11

RHD affects all cardiac valves to varying degrees

12,13

and

remains the predominant cause of mitral regurgitation (MR)

in geographically low- and middle-income regions, including

the South African context.

12

While rheumatic MR has been well

documented in some parts of SA,

12,14-16

uncertainty remains about

the disease characteristics in the KZN population.

Approximately 30 years ago, Marcus

et al

.

14

published a study

on 700 patients with rheumatic valvular heart disease from Chris

Hani Baragwanath Academic Hospital (CHBAH) in which he

detailed demographic, echocardiographic and surgical data on

MR. These data revealed a disease process mainly affecting

young individuals with concomitant acute rheumatic carditis.

14

In a study in 1989, Marcus

et al

.

15

performed echocardiographic

analyses on 73 young patients (mean age 13 years) with acute

rheumatic carditis and severe MR. Here the majority (94%) of

the study population had anterior mitral leaflet (AML) prolapse,

as noted on the echocardiogram and confirmed at surgery. It

was concluded that the mechanism of severe rheumatic MR in

acute carditis was mainly due to annular dilatation and chordal

elongation.

15

In a more recent prospective cross-sectional study at the

CHBAH, Meel

et al

.

16

described a change in the demographic

Department of Internal Medicine, University of KwaZulu-

Natal, Durban, South Africa

Nomthandazo Lynn Zwane, MB BCh, MMed (UKZN), FCP (SA)

Department of Cardiology, University of KwaZulu-Natal,

Durban, South Africa

Somalingum Ponnusamy, MB ChB, FCP (SA), Cert Cardiol

(Physicians) (SA)

Datshana Prakesh Naidoo, MD, FRCP,

naidood@ukzn.ac.za